About

ThiraMed is a Greece-based healthtech startup revolutionizing medical tourism by connecting UK patients to EU-regulated Greek clinics for safe, personalized, and minimally invasive cosmetic care. Combining advanced technology with a dual-country model, ThiraMed bridges the gap between affordability and safety by offering pre- and post-procedure support in the UK and delivering treatments in Greece. Unlike traditional agencies, we don’t sell travel—we deliver outcomes. Our mission is to rebuild trust in medical tourism by ensuring clinical quality, transparency, and continuity through a streamlined, patient-first journey.

Solution & Product

ThiraMed offers a seamless, tech-enabled medical tourism experience for aesthetic procedures. Our proprietary algorithm matches patients with doctor-led Greek clinics based on detailed profiles including medical history, preferences, and schedule. Our mobile app facilitates the full care cycle—from pre-assessment and clinic matching to post-treatment follow-up—with features like recovery plans, translated medical notes, and logistical support. This dual-country model—UK pre/post-care + Greece procedures—ensures safety, transparency, and personalized results, addressing key pain points of decision fatigue, poor follow-up, and safety risks abroad.

Innovation & Scalability

ThiraMed introduces an innovative dual-country healthcare model powered by AI-driven personalization and app-based continuity. Unlike competitors, we integrate local UK care with trusted EU treatments, tackling regulatory gaps and follow-up failures that plague medical tourism. Our scalable tech includes a proprietary algorithm and patient-facing app, both of which can be licensed to facilitators in other markets. With low fixed costs and high-margin partnerships, ThiraMed is designed for rapid regional expansion across Europe and into the Middle East and North America, while keeping patient outcomes at its core.

Traction & achievements

Since inception, ThiraMed is in advanced talks with 10+ EU-regulated, doctor-led clinics in Greece, and has built a strong pipeline of UK patients seeking safe, affordable aesthetic care. We’ve launched a working prototype of our app and algorithm, and early interest from UK clinicians and influencers underscores demand. The model has gained attention for its regulatory alignment with upcoming UK legislation on injectables, giving us a competitive edge.

Team & Why Us

ThiraMed is led by a mission-driven team with deep clinical, strategic, and business expertise. co-founder Dr. Odysseas Drosos (Cambridge doctor, LBS MBA) brings healthcare strategy and operational excellence, while co-founder Dr. Sibel Huet (London doctor, aesthetic clinic founder) combines clinical training in internal medicine and aesthetics with experience in psychodermatology and medical education. Together, we bridge the gap between clinical rigor and scalable business. Our insider knowledge of both the UK and Greek systems uniquely positions us to reshape cross-border care—safely, transparently, and with patient outcomes as our metric of success.

Funding Needs

We are seeking €750K in seed funding to accelerate platform development, expand clinic partnerships, and launch targeted marketing campaigns in the UK. Funds will be allocated to enhance our matching algorithm and patient app, build our clinical referral network, and drive user acquisition through digital channels. This investment will enable us to capture early market share and establish our brand as the go-to platform for safe, affordable aesthetic procedures. Strategic investors with healthcare, tech, or travel expertise will play a pivotal role in our scaling journey.